KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,710,000 | -32.3% | 125,142 | -9.1% | 0.00% | -100.0% |
| Q2 2022 | $2,524,000 | +14.0% | 137,704 | 0.0% | 0.00% | – |
| Q1 2022 | $2,214,000 | -84.8% | 137,704 | -86.8% | 0.00% | -100.0% |
| Q4 2021 | $14,596,000 | +10.6% | 1,042,590 | +47.9% | 0.00% | 0.0% |
| Q3 2021 | $13,203,000 | -70.0% | 704,918 | -66.7% | 0.00% | -71.4% |
| Q2 2021 | $44,078,000 | -7.6% | 2,114,091 | +25.3% | 0.01% | -12.5% |
| Q1 2021 | $47,709,000 | +9.3% | 1,687,618 | +26.2% | 0.01% | 0.0% |
| Q4 2020 | $43,661,000 | +364.4% | 1,336,829 | +335.7% | 0.01% | +300.0% |
| Q3 2020 | $9,401,000 | +3645.4% | 306,793 | +2197.2% | 0.00% | – |
| Q1 2018 | $251,000 | – | 13,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |